Roche has signed an agreement to acquire Innovatis, a German-based provider of automated cell analysis solutions, for $19.4 million. Innovatis will become a fully-integrated part of Roche Applied Science, the company’s diagnostic division. Innovatis will develop and market products for cell analysis through Roche’s worldwide network. The transaction is expected to close within the next few weeks. “This acquisition is a further step in our strategy to strengthen our position as a complete ...